Compare OVID & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | GLAD |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 441.5M |
| IPO Year | 2017 | N/A |
| Metric | OVID | GLAD |
|---|---|---|
| Price | $2.74 | $19.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $4.60 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 3.4M | 162.8K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.78% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | $15.16 |
| Revenue Next Year | $19.34 | $5.10 |
| P/E Ratio | ★ N/A | $11.70 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.36 | $16.54 |
| 52 Week High | $3.11 | $29.50 |
| Indicator | OVID | GLAD |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 52.70 |
| Support Level | $2.23 | $18.80 |
| Resistance Level | $3.05 | $19.44 |
| Average True Range (ATR) | 0.19 | 0.41 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 86.05 | 66.98 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.